AI-Powered Digital Twins Enable Early Alzheimer’s Diagnosis with 88% Accuracy
Early diagnosis has been made possible by a digital twin model (DADD) that derives personalized Alzheimer’s disease (AD) biomarkers from non-invasive electroencephalographic (EEG) recordings. DADD model could identify early stage alzheimer’s with 79% accuracy while also identifying cerebrospinal fluid biomarkers with 88% accuracy and future cognitive decline with 87% accuracy using only non-invasive data. The DADD model enables scalable, low-cost screening and early intervention for preclinical AD such as subjective cognitive decline (SCD), reducing reliance on invasive tests with strong diagnostic and prognostic value.
AI-Powered Digital Twins Enable Early Alzheimer’s Diagnosis with 88% Accuracy Read More »





